Variable | Value |
---|---|
Age (years)a | 64 [45–76] |
PSA (ng/mL)b | 8.4 (± 5.6) |
MRI equipment | |
3 T SIGNA™ Architect, General Electrics | 11 (27%) |
3 T MAGNETOM™ Skyra, Siemens Healthcare | 29 (73%) |
Prostate Volume (cm3)a,c | 57.8 [15–199] |
PI-RADS | |
PI-RADS 1–2 | 23 (57.5%) |
PI-RADS 3 | 4 (10%) |
PI-RADS 4 | 6 (15%) |
PI-RADS 5 | 7 (17.5%) |
Tumor location evaluated on MRI | |
Peripheral zone (PZ) | 10 (25%) |
Transitional zone (TZ) | 7 (17%) |